Selon un bulletin du cabinet chinois Liu, Shen & Associates le nouveau guide d’examen des brevets en Chine (“Chinese Patent Examination Guidelines”) comprend les directives suivantes (en anglais):
- Non-enablement Is No Longer a Defense for Novelty of Compound Inventions
- Chemical Product Characterized By Physical/Chemical Parameters Is Not Recommended
- Novelty of Medical Use Claims Will Be Strictly Examined
- Experimental Data Are Required for All Chemical Products Inventions
- Inventions Relevant to Embryonic Stem Cells Are Unpatentable
- Microorganism Derivatives Claims Are Unacceptable
- Computer Program Medium Is Still Unpatentable
- Three-element Criterion for Invention Relating to Computer Program Is Reconfirmed
- Means Plus Function Is Now Allowable for Defining Product Claim for Invention Relating to Computer Program
- Additional Showing Required in Establishing Novelty of Claimed Product Having Elements such as Performances or Purposes